欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (2): 174-179.

• 基础研究 • 上一篇    下一篇

阻断Notch1信号通路对慢性乙肝患者外周血T细胞免疫功能的影响

刘雪妮, 裴金仙, 李小亮, 臧国庆, 余永胜   

  1. 上海交通大学附属第六人民医院感染病科,上海 200233
  • 收稿日期:2011-02-01 修回日期:2011-02-12 发布日期:2011-04-20
  • 通讯作者: 余永胜,男,主任医师,硕导,研究方向:乙型病毒性肝炎的免疫机制。E-mail: yuyongsheng@medmail.com
  • 作者简介:刘雪妮,女,硕士研究生,研究方向:乙型病毒性肝炎的免疫机制。Tel: 15800853235 E-mail: zsk370@163.com

Effect of blockage of Notch1 signaling on the activation of T cellular immunity in peripheral blood mononuclear cells of patients with chronic hepatitis B

LIU Xue-ni, PEI Jin-xian, LI Xiao-liang, ZANG Guo-qing, YU Yong-sheng   

  1. Department of Infectious Diseases, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
  • Received:2011-02-01 Revised:2011-02-12 Published:2011-04-20

摘要: 目的:观察阻断Notch1信号对慢性乙型病毒性肝炎患者外周血单个核细胞(PBMC)T-bet表达,Th1和Th2型细胞因子表达以及细胞毒性T淋巴细胞(CTL)细胞毒活性的影响,探讨Notch1信号通路在调节慢性乙型病毒性肝炎患者外周血T细胞免疫功能的作用。方法: 将慢性乙型病毒性肝炎患者PBMC随机分为实验组,阴性对照组和空白对照组,分别给予抗-Notch1,IgG2b和RPMI-1640培养液,采用实时荧光定量PCR(real-time Q-PCR)检测各组T-bet mRNA的表达情况,采用ELISA法检测Th1型细胞因子IFN-γ,IL-2和Th2型细胞因子IL-4,IL-10的分泌水平,采用乳酸脱氢酶释放法检测CTL对靶细胞HepG2.2.15细胞毒活性的变化。结果: 用抗体阻断Notch1信号通路后,慢性乙型病毒性肝炎患者PBMC中T-bet mRNA表达增强,Th1型细胞因子IFN-γ和IL-2浓度增高,而Th2型细胞因子IL-4和IL-10浓度减少,且CTL细胞毒活性明显增强,与阴性对照组和空白对照组相比差异有统计学意义(P均<0.01)。结论:阻断Notch1信号通路可增强慢性乙肝患者PBMC中T-bet mRNA表达,使Th1型细胞因子分泌增加,Th2型细胞因子分泌减少,且使CTL细胞毒活性增强,说明阻断Notch1信号通路可增强慢性乙肝患者T细胞免疫反应,Notch1信号通路可能参与慢性乙型病毒性肝炎患者机体的免疫耐受,且可能与T-bet有关。

关键词: 慢性乙肝, Notch1, T细胞免疫, T-bet, CTL

Abstract: AIM: To investigate the influence of Notch1 signaling on expression of T-bet, Th1- and Th2-type cytokines and cytotoxic T-lymphocyte (CTL) cytotoxicity of peripheral blood mononuclear cells (PBMC) of patients with chronic hepatitis B, and analyze the possible function of Notch1 signaling on regulating the activation of T cellular immunity.METHODS: PBMC of patients with chronic hepatitis B were divided into test group, negative control group and blank control group, respectively was given anti-Notch1, IgG2b and RPMI-1640. The expression of T-bet mRNA was examined by real-time PCR, Th1-type cytokines IFN-γ,IL-2, Th2-type cytokines IL-4,IL-10 were assayed by enzyme-linked immunosorbent assay (ELISA) and CTL cytotoxicity was measured by Cytotoxicity Detection Assay (LDH).RESULTS:After Notch1 signaling of PBMC was blocked in chronic hepatitis B patients, expression of T-bet mRNA and the production of Th1-type cytokines IFN-γ,IL-2 were enhanced while Th2-type cytokines IL-4,IL-10 were decreased, and CTL cytotoxicity was enhanced, compared with the blank control groups (P<0.01).CONCLUSION: After blocking of Notch1 signaling of PBMC of chronic hepatitis B patients, the expression of T-bet mRNA and the production of Th1-type cytokines IFN-γ,IL-2 were increased, while Th2-type cytokines IL-4,IL-10 were decreased and CTL cytotoxicity was enhanced. It suggested that blockage of Notch1 signaling could activate T cellular immunity of patients with chronic hepatitis B, Notch1 signaling might contribute to immune tolerance of patients with chronic hepatitis B, perhaps related with T-bet.

Key words: Chronic hepatitis B, Notch1, T cellular immunity, T-bet, CTL

中图分类号: